{"id":121373,"date":"2026-11-17T00:22:40","date_gmt":"2026-11-16T23:22:40","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=121373"},"modified":"2026-11-16T10:15:04","modified_gmt":"2026-11-16T09:15:04","slug":"urady-v-usa-vydaly-nove-varovani-popularni-leky-na-cukrovku-a-hubnuti-mohou-zpusobit-trvalou-ztratu-zraku","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2026\/11\/17\/urady-v-usa-vydaly-nove-varovani-popularni-leky-na-cukrovku-a-hubnuti-mohou-zpusobit-trvalou-ztratu-zraku\/","title":{"rendered":"\u00da\u0159ady v USA vydaly nov\u00e9 varov\u00e1n\u00ed: Popul\u00e1rn\u00ed l\u00e9ky na cukrovku a hubnut\u00ed mohou zp\u016fsobit trvalou ztr\u00e1tu zraku"},"content":{"rendered":"<div id=\"fb-root\"><\/div>\n<p><strong><span dir=\"auto\">L\u00e9ky jako Ozempic, Wegovy \u010di Mounjaro se staly symbolem revoluce v hubnut\u00ed. Miliony lid\u00ed je u\u017e\u00edvaj\u00ed ke sn\u00ed\u017een\u00ed hmotnosti nebo l\u00e9\u010db\u011b cukrovky.<\/span><\/strong><\/p>\n<p><span dir=\"auto\">Nyn\u00ed v\u0161ak americk\u00e9 \u00fa\u0159ady ofici\u00e1ln\u011b upozornily na dal\u0161\u00ed z\u00e1va\u017en\u00e9 riziko &#8211; po\u0161kozen\u00ed zrakov\u00e9ho nervu, kter\u00e9 m\u016f\u017ee v\u00e9st a\u017e k nezvratn\u00e9 ztr\u00e1t\u011b zraku.<\/span><\/p>\n<p><span dir=\"auto\">Americk\u00fd <\/span><em><span dir=\"auto\">\u00da\u0159ad pro kontrolu potravin a l\u00e9\u010div<\/span><\/em><span dir=\"auto\"> (FDA) vydal 9. listopadu 2026 <\/span><a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-communications\/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noopener\"><span dir=\"auto\">nov\u00e9 bezpe\u010dnostn\u00ed upozorn\u011bn\u00ed<\/span><\/a><span dir=\"auto\"> . V\u00fdrobc\u016fm l\u00e9k\u016f ze skupiny GLP-1 na\u0159\u00eddil doplnit varov\u00e1n\u00ed p\u0159ed vz\u00e1cn\u00fdm onemocn\u011bn\u00edm zvan\u00fdm nearteritick\u00e1 p\u0159edn\u00ed ischemick\u00e1 neuropatie zrakov\u00e9ho nervu (NAION).<\/span><\/p>\n<p><span dir=\"auto\">Jedn\u00e1 se o v\u00e1\u017en\u00e9 po\u0161kozen\u00ed zrakov\u00e9ho nervu zp\u016fsoben\u00e9 nedostate\u010dn\u00fdm prokrven\u00edm. Obvykle postihuje jedno oko, nastupuje n\u00e1hle a bez bolesti. Ztr\u00e1ta zraku p\u0159itom b\u00fdv\u00e1 trval\u00e1.<\/span><\/p>\n<p><span dir=\"auto\">Farmaceutick\u00e9 spole\u010dnosti l\u00e9ta propaguj\u00ed tyto l\u00e9ky jako v\u00fdznamn\u00fd pokrok v l\u00e9\u010db\u011b cukrovky a obezity. O jejich p\u0159\u00ednosech se hovo\u0159\u00ed hodn\u011b, ale z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky si zaslou\u017e\u00ed stejnou pozornost. Zejm\u00e9na pokud pacienti riskuj\u00ed po\u0161kozen\u00ed jednoho z nejd\u016fle\u017eit\u011bj\u0161\u00edch smysl\u016f.<\/span><\/p>\n<h2><span dir=\"auto\">Co odhalila anal\u00fdza v\u00edce ne\u017e 134 tis\u00edc pacient\u016f<\/span><\/h2>\n<p><span dir=\"auto\">FDA sv\u00e9 rozhodnut\u00ed neop\u0159el pouze o jednotliv\u00e1 hl\u00e1\u0161en\u00ed pacient\u016f. P\u0159ezkoumal \u00fadaje ze 126 kontrolovan\u00fdch klinick\u00fdch studi\u00ed, kter\u00fdch se z\u00fa\u010dastnilo celkem 134 253 lid\u00ed.<\/span><\/p>\n<p><span dir=\"auto\">V\u00fdsledky uk\u00e1zaly:<\/span><\/p>\n<ul>\n<li><strong><span dir=\"auto\">6,4 p\u0159\u00edpadu NAION na 100 000 osoborok\u016f<\/span><\/strong><span dir=\"auto\"> u pacient\u016f u\u017e\u00edvaj\u00edc\u00edch l\u00e9ky GLP-1.<\/span><\/li>\n<li><strong><span dir=\"auto\">3,8 p\u0159\u00edpadu na 100 000 osoborok\u016f<\/span><\/strong><span dir=\"auto\"> v kontroln\u00edch skupin\u00e1ch, kter\u00e9 dost\u00e1valy placebo nebo jinou l\u00e9\u010dbu.<\/span><\/li>\n<\/ul>\n<p><span dir=\"auto\">To p\u0159edstavuje p\u0159ibli\u017en\u011b <\/span><strong><span dir=\"auto\">o 68% vy\u0161\u0161\u00ed v\u00fdskyt po\u0161kozen\u00ed zrakov\u00e9ho nervu<\/span><\/strong><span dir=\"auto\"> ve skupin\u011b u\u017e\u00edvaj\u00edc\u00ed GLP-1.<\/span><\/p>\n<p><span dir=\"auto\">Osoboroky zohled\u0148uj\u00ed po\u010det pacient\u016f i d\u00e9lku jejich sledov\u00e1n\u00ed. V cel\u00e9 anal\u00fdze FDA identifikoval 15 pravd\u011bpodobn\u00fdch p\u0159\u00edpad\u016f NAION \u2013 deset u pacient\u016f u\u017e\u00edvaj\u00edc\u00edch GLP-1 a p\u011bt v kontroln\u00edch skupin\u00e1ch.<\/span><\/p>\n<p><span dir=\"auto\">Jedn\u00e1 se tedy o vz\u00e1cnou komplikaci, ale s potenci\u00e1ln\u011b zni\u010duj\u00edc\u00edmi n\u00e1sledky. \u00da\u010dinn\u00e1 l\u00e9\u010dba, kter\u00e1 by ji\u017e po\u0161kozen\u00fd zrakov\u00fd nerv obnovila, v sou\u010dasnosti neexistuje.<\/span><\/p>\n<p><span dir=\"auto\">Ne v\u0161echny anal\u00fdzy FDA p\u0159inesly stejn\u00e9 v\u00fdsledky, ale celkov\u00e9 d\u016fkazy byly dostate\u010dn\u011b z\u00e1va\u017en\u00e9 na to, aby \u00fa\u0159ad na\u0159\u00eddil nov\u00e1 upozorn\u011bn\u00ed pro celou skupinu l\u00e9k\u016f.<\/span><\/p>\n<p><span dir=\"auto\">Mezi dot\u010den\u00e9 p\u0159\u00edpravky pat\u0159\u00ed Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity a dal\u0161\u00ed.<\/span><\/p>\n<h2><span dir=\"auto\">Evropsk\u00e9 \u00fa\u0159ady potvrdily riziko ji\u017e d\u0159\u00edve<\/span><\/h2>\n<p><span dir=\"auto\">Americk\u00e9 rozhodnut\u00ed nep\u0159ich\u00e1z\u00ed z ni\u010deho nic. Evropsk\u00e1 agentura pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) ji\u017e v \u010dervnu 2025 dosp\u011bla k z\u00e1v\u011bru, \u017ee NAION je vz\u00e1cn\u00fdm ne\u017e\u00e1douc\u00edm \u00fa\u010dinkem semaglutidu, \u00fa\u010dinn\u00e9 l\u00e1tky v l\u00e9c\u00edch Ozempic, Wegovy a Rybelsus.<\/span><\/p>\n<p><span dir=\"auto\">Evrop\u0161t\u00ed regul\u00e1to\u0159i za\u0159adili NAION mezi velmi vz\u00e1cn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, kter\u00e9 postihuj\u00ed nejv\u00fd\u0161e jednoho z 10 000 u\u017eivatel\u016f. Podle v\u00fdsledk\u016f epidemiologick\u00fdch studi\u00ed z\u00e1rove\u0148 l\u00e9\u010dba semaglutidem souvis\u00ed p\u0159ibli\u017en\u011b s jedn\u00edm dodate\u010dn\u00fdm p\u0159\u00edpadem NAION na 10 000 osoborok\u016f.<\/span><\/p>\n<p><span dir=\"auto\">N\u011bkolik rozs\u00e1hl\u00fdch pozorovac\u00edch studi\u00ed zjistilo p\u0159ibli\u017en\u011b dvojn\u00e1sobn\u00e9 riziko u pacient\u016f s diabetem 2. typu u\u017e\u00edvaj\u00edc\u00edch semaglutid.<\/span><\/p>\n<p><span dir=\"auto\">Je pozoruhodn\u00e9, \u017ee tyto l\u00e9ky se ji\u017e l\u00e9ta masov\u011b p\u0159edepisuj\u00ed, zat\u00edmco informace o n\u011bkter\u00fdch z\u00e1va\u017en\u00fdch rizic\u00edch se do ofici\u00e1ln\u00edch upozorn\u011bn\u00ed dost\u00e1vaj\u00ed a\u017e nyn\u00ed.<\/span><\/p>\n<p><span dir=\"auto\">To vyvol\u00e1v\u00e1 nep\u0159\u00edjemnou ot\u00e1zku: Kolik pacient\u016f by se k l\u00e9\u010db\u011b rozhodlo jinak, kdyby m\u011bly tyto informace k dispozici ji\u017e p\u0159i jej\u00edm zah\u00e1jen\u00ed?<\/span><\/p>\n<h2><span dir=\"auto\">V\u00fdrobce \u010delil kritice za z\u00e1va\u017en\u00e1 selh\u00e1n\u00ed p\u0159i hl\u00e1\u0161en\u00ed ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f<\/span><\/h2>\n<p><span dir=\"auto\">D\u016fv\u011bru v bezpe\u010dnostn\u00ed dohled nad t\u011bmito l\u00e9ky na\u0161t\u011brbil i dal\u0161\u00ed p\u0159\u00edpad.<\/span><\/p>\n<p><span dir=\"auto\">FDA vydal 5. b\u0159ezna 2026 form\u00e1ln\u00ed varovn\u00fd dopis farmaceutick\u00e9 spole\u010dnosti Novo Nordisk, v\u00fdrobci Ozempicu a Wegovy. Kontrola odhalila z\u00e1va\u017en\u00e1 poru\u0161en\u00ed povinnost\u00ed p\u0159i zaznamen\u00e1v\u00e1n\u00ed, prov\u011b\u0159ov\u00e1n\u00ed a hl\u00e1\u0161en\u00ed ne\u017e\u00e1douc\u00edch ud\u00e1lost\u00ed.<\/span><\/p>\n<p><span dir=\"auto\">\u00da\u0159ad popsal p\u0159\u00edpady, kdy spole\u010dnost nespr\u00e1vn\u011b zpracovala nebo v\u010das nenahl\u00e1sila z\u00e1va\u017en\u00e9 ud\u00e1losti v\u010detn\u011b mozkov\u00fdch p\u0159\u00edhod, sebevra\u017eedn\u00fdch my\u0161lenek a \u00famrt\u00ed pacient\u016f.<\/span><\/p>\n<p><span dir=\"auto\">Samotn\u00e9 hl\u00e1\u0161en\u00ed je\u0161t\u011b nedokazuje, \u017ee ud\u00e1lost zp\u016fsobil konkr\u00e9tn\u00ed l\u00e9k. V\u00fdrobce m\u00e1 v\u0161ak povinnost takov\u00e9 p\u0159\u00edpady \u0159\u00e1dn\u011b vy\u0161et\u0159it a nahl\u00e1sit bez ohledu na to, zda se p\u0159\u00ed\u010dinn\u00e1 souvislost potvrdila.<\/span><\/p>\n<p><span dir=\"auto\">A pr\u00e1v\u011b zde regul\u00e1to\u0159i odhalili v\u00e1\u017en\u00e1 selh\u00e1n\u00ed.<\/span><\/p>\n<p><span dir=\"auto\">Pokud farmaceutick\u00e1 spole\u010dnost nedok\u00e1\u017ee spolehliv\u011b plnit ani z\u00e1kladn\u00ed povinnosti p\u0159i sledov\u00e1n\u00ed bezpe\u010dnosti sv\u00fdch produkt\u016f, pro\u010d by m\u011bli pacienti bezv\u00fdhradn\u011b d\u016fv\u011b\u0159ovat jej\u00edm uji\u0161t\u011bn\u00edm o jejich rizic\u00edch?<\/span><\/p>\n<p><span dir=\"auto\">Novo Nordisk p\u0159itom nad\u00e1le zast\u00e1v\u00e1 stanovisko, \u017ee dostupn\u00e9 \u00fadaje nepotvrzuj\u00ed p\u0159\u00ed\u010dinnou souvislost mezi jeho l\u00e9ky a NAION. Evrop\u0161t\u00ed regul\u00e1to\u0159i v\u0161ak ji\u017e toto onemocn\u011bn\u00ed ofici\u00e1ln\u011b za\u0159adili mezi velmi vz\u00e1cn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky semaglutidu a americk\u00fd FDA nyn\u00ed roz\u0161\u00ed\u0159il bezpe\u010dnostn\u00ed varov\u00e1n\u00ed na celou skupinu GLP-1.<\/span><\/p>\n<h2><span dir=\"auto\">Jak doch\u00e1z\u00ed k po\u0161kozen\u00ed zraku<\/span><\/h2>\n<p><span dir=\"auto\">NAION vznik\u00e1 p\u0159i nedostate\u010dn\u00e9m p\u0159\u00edvodu krve do p\u0159edn\u00ed \u010d\u00e1sti zrakov\u00e9ho nervu. Nervov\u00e9 bu\u0148ky n\u00e1sledn\u011b trp\u00ed nedostatkem kysl\u00edku a \u010d\u00e1st z nich odum\u00edr\u00e1.<\/span><\/p>\n<p><span dir=\"auto\">P\u0159esn\u00fd mechanismus, kter\u00fdm l\u00e9ky GLP-1 souvis\u00ed s t\u00edmto po\u0161kozen\u00edm, zat\u00edm nen\u00ed objasn\u011bn. Zn\u00e1m\u00e9 jsou v\u0161ak faktory, kter\u00e9 zvy\u0161uj\u00ed riziko samotn\u00e9ho onemocn\u011bn\u00ed:<\/span><\/p>\n<ul>\n<li><a href=\"https:\/\/www.badatel.net\/analyza-54-vedeckych-studii-odhalila-4-rastliny-na-vrchole-rebricka-proti-cukrovke\/\"><span dir=\"auto\">cukrovka<\/span><\/a><span dir=\"auto\"> a po\u0161kozen\u00ed drobn\u00fdch c\u00e9v<\/span><\/li>\n<li><span dir=\"auto\">vysok\u00fd krevn\u00ed tlak<\/span><\/li>\n<li><span dir=\"auto\">sp\u00e1nkov\u00e1 apnoe<\/span><\/li>\n<li><span dir=\"auto\">kou\u0159en\u00ed<\/span><\/li>\n<li><span dir=\"auto\">n\u011bkter\u00e9 poruchy krevn\u00edho ob\u011bhu<\/span><\/li>\n<\/ul>\n<p><span dir=\"auto\">Pr\u00e1v\u011b pacienti s cukrovkou a obezitou \u010dasto trp\u00ed v\u00edce z t\u011bchto probl\u00e9m\u016f sou\u010dasn\u011b.<\/span><\/p>\n<p><span dir=\"auto\">To je dal\u0161\u00ed d\u016fvod, pro\u010d by l\u00e9\u010dba nem\u011bla st\u00e1t pouze na injekc\u00edch. Kontrola hladiny cukru v krvi, krevn\u00edho tlaku, pravideln\u00fd pohyb, kvalitn\u00ed strava a dostatek sp\u00e1nku z\u016fst\u00e1vaj\u00ed z\u00e1kladem ochrany c\u00e9v i zraku.<\/span><\/p>\n<p><span dir=\"auto\">L\u00e9ky GLP-1 maj\u00ed prok\u00e1zan\u00e9 p\u0159\u00ednosy p\u0159i cukrovce a obezit\u011b a n\u011bkter\u00e9 sni\u017euj\u00ed i \u200b\u200briziko v\u00e1\u017en\u00fdch srde\u010dn\u011b-c\u00e9vn\u00edch komplikac\u00ed. Jejich \u00fa\u010dinnost v\u0161ak nen\u00ed d\u016fvodem bagatelizovat ne\u017e\u00e1douc\u00ed \u00fa\u010dinky.<\/span><\/p>\n<h2><span dir=\"auto\">Varovn\u00e9 p\u0159\u00edznaky, kter\u00e9 nesm\u00edte ignorovat<\/span><\/h2>\n<p><span dir=\"auto\">Po\u0161kozen\u00ed zrakov\u00e9ho nervu typu NAION se \u010dasto objev\u00ed n\u00e1hle, n\u011bkdy hned po probuzen\u00ed. Obvykle nebol\u00ed, tak\u017ee pacient si zpo\u010d\u00e1tku nemus\u00ed uv\u011bdomit z\u00e1va\u017enost situace.<\/span><\/p>\n<p><span dir=\"auto\">Mezi typick\u00e9 p\u0159\u00edznaky pat\u0159\u00ed:<\/span><\/p>\n<ul>\n<li><span dir=\"auto\">n\u00e1hl\u00e9 zhor\u0161en\u00ed nebo ztr\u00e1ta zraku na jednom oku<\/span><\/li>\n<li><span dir=\"auto\">rozmazan\u00e9 \u010di zaml\u017een\u00e9 vid\u011bn\u00ed<\/span><\/li>\n<li><span dir=\"auto\">tmav\u00e1 nebo slep\u00e1 m\u00edsta v zorn\u00e9m poli<\/span><\/li>\n<li><span dir=\"auto\">zhor\u0161en\u00e9 vn\u00edm\u00e1n\u00ed barev<\/span><\/li>\n<li><span dir=\"auto\">v\u00fdpadek \u010d\u00e1sti zorn\u00e9ho pole<\/span><\/li>\n<\/ul>\n<p><span dir=\"auto\">P\u0159i takov\u00fdch p\u0159\u00edznac\u00edch je nezbytn\u00e9 okam\u017eit\u00e9 o\u010dn\u00ed vy\u0161et\u0159en\u00ed. N\u00e1hl\u00e1 ztr\u00e1ta zraku toti\u017e signalizuje i jin\u00e1 urgentn\u00ed onemocn\u011bn\u00ed.<\/span><\/p>\n<p><span dir=\"auto\">Pokud se NAION potvrd\u00ed, l\u00e9ka\u0159 mus\u00ed p\u0159ehodnotit dal\u0161\u00ed u\u017e\u00edv\u00e1n\u00ed p\u0159\u00edpravku. Evropsk\u00e1 l\u00e9kov\u00e1 agentura p\u0159i potvrzen\u00e9m NAION doporu\u010duje l\u00e9\u010dbu semaglutidem ukon\u010dit.<\/span><\/p>\n<p><span dir=\"auto\">Bez p\u0159\u00edznak\u016f v\u0161ak pacienti nemaj\u00ed l\u00e9\u010dbu sv\u00e9voln\u011b p\u0159eru\u0161ovat. Zejm\u00e9na u cukrovky by vysazen\u00ed bez n\u00e1hradn\u00edho postupu mohlo v\u00e9st ke zhor\u0161en\u00ed zdravotn\u00edho stavu.<\/span><\/p>\n<h2><span dir=\"auto\">Zdrav\u00ed by nem\u011blo st\u00e1t na jedn\u00e9 injekci<\/span><\/h2>\n<p><span dir=\"auto\">Nov\u00e9 varov\u00e1n\u00ed FDA p\u0159ipom\u00edn\u00e1, \u017ee ani modern\u00ed a mimo\u0159\u00e1dn\u011b \u00fa\u010dinn\u00e9 l\u00e9ky nejsou bez rizika. Vedle tr\u00e1vic\u00edch pot\u00ed\u017e\u00ed, probl\u00e9m\u016f se \u017elu\u010dn\u00edkem \u010di slinivkou b\u0159i\u0161n\u00ed se nyn\u00ed do pop\u0159ed\u00ed dost\u00e1v\u00e1 i po\u0161kozen\u00ed zrakov\u00e9ho nervu s potenci\u00e1ln\u011b trval\u00fdmi n\u00e1sledky.<\/span><\/p>\n<p><span dir=\"auto\">Pro mnoho pacient\u016f s cukrovkou nebo z\u00e1va\u017enou obezitou p\u0159\u00ednosy l\u00e9\u010dby p\u0159ev\u00e1\u017e\u00ed rizika. To v\u0161ak nezbavuje v\u00fdrobce ani regula\u010dn\u00ed \u00fa\u0159ady odpov\u011bdnosti za v\u010dasn\u00e9 odhalov\u00e1n\u00ed a zve\u0159ej\u0148ov\u00e1n\u00ed ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f.<\/span><\/p>\n<p><span dir=\"auto\">Farmaceutick\u00e9 spole\u010dnosti investuj\u00ed miliardy do v\u00fdvoje a propagace nov\u00fdch l\u00e9k\u016f. Pacienti maj\u00ed pr\u00e1vo o\u010dek\u00e1vat, \u017ee stejn\u011b d\u016fsledn\u011b budou zkoum\u00e1na a zve\u0159ej\u0148ov\u00e1na i jejich rizika.<\/span><\/p>\n<p><span dir=\"auto\">Kdy\u017e jde o zrak, kter\u00fd se po po\u0161kozen\u00ed zrakov\u00e9ho nervu ji\u017e nemus\u00ed nikdy obnovit, ka\u017ed\u00e9 opo\u017ed\u011bn\u00e9 bezpe\u010dnostn\u00ed upozorn\u011bn\u00ed vyvol\u00e1v\u00e1 opr\u00e1vn\u011bn\u00e9 ot\u00e1zky.<\/span><\/p>\n<p><strong><span dir=\"auto\">Zrak je p\u0159\u00edli\u0161 vz\u00e1cn\u00fd na to, aby se o takov\u00fdch rizic\u00edch ml\u010delo.<\/span><\/strong><\/p>\n<p><span dir=\"auto\">Autor: Mike Adams, Zdroj: <\/span><a href=\"https:\/\/www.naturalnews.com\/2026-11-10-fda-admits-glp-1-drugs-cause-blindness.html\" target=\"_blank\" rel=\"noopener\"><span dir=\"auto\">naturalnews.com<\/span><\/a><span dir=\"auto\">\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u00e9ky jako Ozempic, Wegovy \u010di Mounjaro se staly symbolem revoluce v hubnut\u00ed. Miliony lid\u00ed je&#8230;<\/p>\n","protected":false},"author":2,"featured_media":121374,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[6220,1020,5744,37,1402,8673],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/121373"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=121373"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/121373\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/121374"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=121373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=121373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=121373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}